Patents by Inventor Jang-Ming Lee

Jang-Ming Lee has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Optical method for predicting treatment response, survival and recurrence of esophageal cancer patients
    Patent number: 10746651
    Abstract: The present invention provides an optical method for predicting treatment response, survival and recurrence of esophageal cancer patients, comprising analyzing the spectral signatures of patient's tumor tissue spectra. By the features of the present invention, the prediction result achieves the sensitivity of 75% and specificity of 73.3% in concurrent chemoradiotherapy (CCRT) response; the survival prediction rate achieves the sensitivity of 100%; the recurrence prediction rate achieves the sensitivity of 85.7%.
    Type: Grant
    Filed: September 13, 2017
    Date of Patent: August 18, 2020
    Assignee: NATIONAL TAIWAN UNIVERSITY
    Inventors: Jang-Ming Lee, I-Jen Hsu, Max Ti-Kuang Hou, Pei-Wen Yang
  • OPTICAL METHOD FOR PREDICTING TREATMENT RESPONSE, SURVIVAL AND RECURRENCE OF ESOPHAGEAL CANCER PATIENTS
    Publication number: 20190017925
    Abstract: The present invention provides an optical method for predicting treatment response, survival and recurrence of esophageal cancer patients, comprising analyzing the spectral signatures of patient's tumor tissue spectra. By the features of the present invention, the prediction result achieves the sensitivity of 75% and specificity of 73.3% in concurrent chemoradiotherapy (CCRT) response; the survival prediction rate achieves the sensitivity of 100%; the recurrence prediction rate achieves the sensitivity of 85.7%.
    Type: Application
    Filed: September 13, 2017
    Publication date: January 17, 2019
    Inventors: JANG-MING LEE, I-JEN HSU, MAX TI-KUANG HOU, PEI-WEN YANG
  • Biomarkers for predicting response of esophageal cancer patient to chemoradiotherapy
    Publication number: 20130017961
    Abstract: The present invention relates to novel genetic markers associated with response of a patient with esophageal cancer (ECa) to chemoradiation therapy, and particularly to methods and kits for predicting an ECa patient's response to chemoradiation therapy by genotyping of the markers.
    Type: Application
    Filed: August 13, 2012
    Publication date: January 17, 2013
    Applicant: NATIONAL TAIWAN UNIVERSITY
    Inventors: Pei-Chun Chen, Yen-Ching Chen, Liang-Chuan Lai, Mong-Hsun Tsai, Shin-Kuang Chen, Pei-Wen Yang, Jang-Ming Lee, Eric Y. Chuang, Chuhsing K. Hsiao
  • Biomarkers for predicting response of esophageal cancer patient to chemoradiotherapy
    Patent number: 8268562
    Abstract: The present invention relates to novel genetic markers associated with response of a patient with esophageal cancer (ECa) to chemoradiation therapy, and particularly to methods and kits for predicting an ECa patient's response to chemoradiation therapy by genotyping of the markers.
    Type: Grant
    Filed: October 20, 2009
    Date of Patent: September 18, 2012
    Assignee: National Taiwan University
    Inventors: Pei-Chun Chen, Yen-Ching Chen, Liang-Chuan Lai, Mong-Hsun Tsai, Shin-Kuang Chen, Pei-Wen Yang, Jang-Ming Lee, Eric Y. Chuang, Chuhsing K. Hsiao
  • BIOMARKERS FOR PREDICTING RESPONSE OF ESOPHAGEAL CANCER PATIENT TO CHEMORADIOTHERAPY
    Publication number: 20110091871
    Abstract: The present invention relates to novel genetic markers associated with response of a patient with esophageal cancer (ECa) to chemoradiation therapy, and particularly to methods and kits for predicting an ECa patient's response to chemoradiation therapy by genotyping of the markers.
    Type: Application
    Filed: October 20, 2009
    Publication date: April 21, 2011
    Applicant: National Taiwan University
    Inventors: Pei-Chun Chen, Yen-Ching Chen, Liang-Chuan Lai, Mong-Hsun Tsai, Shin-Kuang Chen, Pei-Wen Yang, Jang-Ming Lee, Eric Y. Chuang, Chuhsing K. Hsiao
  • Transgenic swine having HLA-D gene, swine cells thereof and xenografts therefrom
    Patent number: 6639122
    Abstract: The invention provides a transgenic swine having a transgene encoding a human HLA-DQ or HLA-DR protein, and the swine cells thereof. The invention also provides a graft derived from the transgenic swine, in particular a graft-organ or a graft-tissue, which is useful for grafting into a human recipient.
    Type: Grant
    Filed: September 19, 2000
    Date of Patent: October 28, 2003
    Assignee: Animal Technology Institute Taiwan
    Inventors: Ching-Fu Tu, Chun-Jean Lee, Jang-Ming Lee, Kimiyoshi Tsuji